regulatory
confidence high
sentiment negative
materiality 0.80
Strive, Inc. (ASST): Nasdaq/NYSE listing notice — Asset Entities receives Nasdaq minimum bid price deficiency notice; extends equity line with Triton to Dec 30, 2023
Strive, Inc.
- Nasdaq notified ASST on Sep 28, 2023 that stock failed to maintain $1.00 bid for 30 consecutive days; 180-day cure period until Mar 26, 2024.
- Company delivered first closing notice to Triton for 263,410 shares (~4.9% of outstanding) under amended equity line with $1M capacity, extended to Dec 30, 2023.
- Purchase price for Triton shares set at 85% of lowest VWAP over five business days after delivery; closing within five business days after receipt.
- Boustead Securities entitled to 7% cash fee and 1% expense allowance, plus warrant for 18,439 shares on this closing.
- Company may sell additional shares to Triton up to $1M aggregate value less first tranche until Dec 30, 2023.